OBiO Technology, based in Shanghai, China, is a cell and gene therapy–focused CRO/CDMO that provides integrated research, development, and manufacturing solutions spanning vector studies, functional genomics, process and analytical development, IND-enabling CMC, and clinical to commercial manufacturing. OBiO offers cGMP manufacturing services for AAV and lentivirus viral vectors, various oncolytic virus products, plasmid DNA products, and nucleotides.